Since the pandemic began, the provincial government has put more than $4 million into VIDO-InterVac, which is at the University of Saskatchewan.
Both Canadian-made vaccines have yet to be approved. VIDO's COVID-19 vaccine, which was developed in the Saskatoon lab, has begun clinical trials. Moe said the earliest the Providence vaccine will arrive is by the end of the year, while VIDO-InterVac's vaccine could come early next year.
Saskatchewan and the federal government have both committed to vaccinating the general population before then.
WATCH
Manitoba premier says province's deal to secure made-in-Canada vaccines is 'insurance'
CBC News Manitoba2 months ago
1:02Manitoba Premier Brian Pallister said Thursday the province has struck a deal to buy two million doses of a Canadian-made COVID-19 vaccine, on the condition it gets approved for use in Canada and is delivered by the end of the year.1:02